Cargando…

Mucosal immunity to SARS-CoV-2: a clinically relevant key to deciphering natural and vaccine-induced defences

Detalles Bibliográficos
Autor principal:	Matuchansky, Claude
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358136/ https://www.ncbi.nlm.nih.gov/pubmed/34391929 http://dx.doi.org/10.1016/j.cmi.2021.08.008

Ejemplares similares

Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?
por: Batista-Liz, Joao Carlos, et al.
Publicado: (2023)

SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative
por: Adashi, Eli Y., et al.
Publicado: (2022)

SARS-CoV-2 vaccination for immune-comprised patients: More is required
por: Li, Hui, et al.
Publicado: (2021)

Platelet size as a mirror for the immune response after SARS‐CoV‐2 vaccination
por: Thiele, Thomas, et al.
Publicado: (2022)

Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Attacking the defence: SARS-CoV-2 can infect immune cells
por: Borsa, Mariana, et al.
Publicado: (2020)

A commentary on “post-SARS-CoV-2-vaccine shoulder pain: Is it relevant to the vaccine injection? – Correspondence” (int J surg 2022;100:106603)
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
por: Focosi, Daniele, et al.
Publicado: (2022)

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination
por: Bomsel, Morgane, et al.
Publicado: (2023)

Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
por: Fraser, Rupsha, et al.
Publicado: (2023)

Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
por: Ikizler, T. Alp, et al.
Publicado: (2021)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response
por: Zhang, Ying, et al.
Publicado: (2021)

IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
por: Fraussen, Judith
Publicado: (2022)

Deciphering the association between HIV-specific immunity and immune reconstitution
por: Søgaard, Ole S.
Publicado: (2021)

The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development
por: Moradi-kalbolandi, Shima, et al.
Publicado: (2021)

The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
por: Chan, Renee W. Y., et al.
Publicado: (2021)

Escape of SARS-CoV-2 Variant Omicron to Mucosal Immunity in Vaccinated Subjects
por: Martinuzzi, Emanuela, et al.
Publicado: (2022)

Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
por: Mitsi, Elena, et al.
Publicado: (2023)

Deciphering the role of natural variation in age-related protein homeostasis
por: Kaeberlein, Matt
Publicado: (2013)

Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
por: Pawelec, Graham, et al.
Publicado: (2021)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
por: Antonopoulou, Tania, et al.
Publicado: (2022)

Questioning the justification for a fourth SARS-CoV-2 vaccine
por: Calderon-Margalit, Ronit, et al.
Publicado: (2022)

Implementing digital passports for SARS-CoV-2 immunization in Canada
por: Wilson, Kumanan, et al.
Publicado: (2021)

A framework for monitoring population immunity to SARS-CoV-2
por: Lopman, Benjamin A., et al.
Publicado: (2021)

SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
por: Sunagar, Raju, et al.
Publicado: (2023)

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
por: Salvatori, Giovanni, et al.
Publicado: (2020)

Pregnant people deserve the protection offered by SARS-CoV-2 vaccines
por: Maykin, Melanie M., et al.
Publicado: (2021)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
por: Cevik, Muge, et al.
Publicado: (2021)

A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity
por: Bellier, Bertrand, et al.
Publicado: (2022)

SARS-CoV-2 vaccines: Potential refinements through induction of mucosal and trained immunity
por: Portilho, Amanda Izeli, et al.
Publicado: (2022)

Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants
por: Kingstad-Bakke, Brock, et al.
Publicado: (2022)

Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
por: Tang, Jinyi, et al.
Publicado: (2022)

Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
por: Bladh, Oscar, et al.
Publicado: (2023)

T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
por: Bsteh, Gabriel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_843svmrfftrja6r5fch5rdkq7k